Abstract
No public abstract is available from the verified source records.
Paolo Coppi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Low-dose rivaroxaban and cardiovascular events in advanced kidney disease: the TRACK randomized clinical trial.
10.1001/jama.2026.9379 · 2026
Rivaroxaban for cardiovascular disease prevention in chronic kidney disease: high risk, but no reward?
10.1001/jama.2026.9780 · 2026
Therapeutic drug monitoring of direct oral anticoagulants and its association with clinical outcomes: a systematic review and meta-analysis.
10.3390/ph19020215 · 2026
No additional external references are available.